Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FENXL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,766
Award facts
- Contract value 100% obligated
- $12,766.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $12,766.02 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This firm fixed-price delivery order, awarded on December 8, 2025, represents one of numerous orders issued to DMS Pharmaceutical Group under the agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The delivery order contains no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and medical consumables to support Department of Defense healthcare operations.
DMS Pharmaceutical Group operates as a prime vendor under the broader $30.3 billion PPV-G GEN V acquisition strategy, holding a single-award Indefinite Delivery Contract (SPE2DR) with a $499.999 billion ceiling value and completion date of December 31, 2036. This underlying master contract, awarded November 13, 2025, positions the company to provide critical pharmaceutical supply support to military healthcare facilities worldwide and consists of a 30-month base period with three 30-month option periods. The current delivery order falls within this master contract framework and reflects the contractor's substantial federal contracting activity and demonstrated performance across multiple therapeutic categories and product lines essential to the Department of Defense's global medical supply chain.
Quick answers
Who was awarded contract SPE2DU26FENXL?
SPE2DU26FENXL was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DU26FENXL worth?
The government has obligated $12,766 on SPE2DU26FENXL.
Is contract SPE2DU26FENXL an order under another contract?
Yes. SPE2DU26FENXL is a delivery order under SPE2DU25D9418, an indefinite delivery contract.
Was contract SPE2DU26FENXL competed?
The extent of competition for SPE2DU26FENXL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award